Why this one keeps showing up
A UTI is the presence of a significant number of pathogenic organisms in the urine with the potential to invade the tissues of the urinary tract and adjacent structures — bladder, urethra, prostate, renal parenchyma, and collecting system. It causes inflammation of the urinary epithelium and is associated with a positive urine culture.
Most common bacterial infection in the elderly
The count that defines infection depends on symptoms and on how the specimen was collected — there is no single universal colony threshold.
The route from UTI to septic shock
Genitourinary infection is the most common cause of sepsis in the elderly. Hypotension plus altered mental status in a patient with flank pain is urosepsis until proven otherwise.
69% of CAUTIs are avoidable
A catheter is a biofilm scaffold. Avoid the catheter, and remove it the day it is no longer medically necessary — that single habit prevents more infection than any antibiotic choice.
- Is the urinary tract structurally and functionally normal? Normal → uncomplicated. A defect or a compromising host condition → complicated. This distinction drives drug choice and duration more than any other variable.
- Is it above or below the bladder? Lower tract → cystitis, urethritis, prostatitis. Upper tract → pyelonephritis and renal abscess. Upper tract means fever, flank pain, and a longer course.
- Is the patient systemically ill? Organ dysfunction or shock → urosepsis, and you are now running a sepsis resuscitation.
Four axes, and they stack
The labels are not academic. Each axis changes either the antibiotic, the route, the duration, or the disposition.
| Axis | Categories | What it changes |
|---|---|---|
| Uncomplicated vs. complicated | Uncomplicated — occurs in a normal working urinary tract. Complicated — occurs with defects in the urinary tract or in individuals with other health problems — diabetes, immunosuppression, multidrug-resistant organisms. | Drug selection and duration. Complicated infection needs broader empiric coverage, longer therapy, and a search for the structural problem. |
| Location | Lower tract — bladder and urethra. Upper tract — kidney and ureters. | Lower tract is a local problem treated orally in 3–5 days. Upper tract means bacteremia risk, longer therapy, and imaging if the patient does not improve. |
| Symptomatic vs. asymptomatic | Asymptomatic bacteriuria — a high colony count with no clinical urinary tract symptoms. Symptomatic — low counts can still reflect true infection when symptoms are present. | Whether to treat at all. Screening for and treating asymptomatic bacteriuria is not indicated except in three groups (below). |
| Catheter-associated | CAUTI — a UTI in a patient who has been catheterized within the past 48 hours. | Catheter removal or exchange, a different organism profile (biofilm, often polymicrobial), and a 3–7 day course in most cases. |
Routine screening is not indicated except in:
- Pregnant women
- Patients undergoing invasive genitourinary procedures
- Renal transplant recipients
Age alone is not an indication, and neither is a personal or family history of UTI. Treating asymptomatic bacteriuria in everyone else produces adverse drug effects and resistance without changing outcomes.
Colony counts — the threshold depends on the question
The number that "counts" is symptom- and specimen-dependent, which is why memorizing a single cutoff fails on exams.
| Setting | Threshold | Interpretation |
|---|---|---|
| Asymptomatic bacteriuria | > 100,000 colonies of one or more bacterial species in two consecutive samples in women and a single sample in men | Bacteriuria / active infection without clinical urinary tract symptoms. Common in men and women who have genitourinary abnormalities. |
| Symptomatic infection | Between 10 and 10,000 colonies | Relatively low colony counts can reflect true bacteriuria in the presence of symptoms. Symptoms outrank the number. |
| Pyuria on microscopy | > 10 leukocytes/mL; bacteriuria > 100,000 bacteria/mL | Pyuria signifies inflammation; the bacteriuria threshold indicates active infection. |
| Clean-catch midstream dipstick | Positive nitrite or leukocyte esterase | Either can diagnose UTI; blood in the urine may also support the diagnosis. |
A UTI is catheter-associated when the patient has been catheterized within the past 48 hours. It is caused by a biofilm — a layer of uropathogens living along the catheter — which is why the organism profile differs from community infection and why exchanging a catheter in place longer than 7 days matters before you treat.
Recurrence, relapse, and reinfection are three different words
Two UTIs in the last 6 months, or three in the last year. This definition is what qualifies a patient for prophylaxis.
Caused by the same uropathogen. Suggests the original infection was never eradicated — think inadequate duration, resistance, or a structural focus such as a stone.
Caused by a different uropathogen. A new event, not a treatment failure — the prevention conversation is the right one here.
After a single UTI, 30–44% have recurrent UTI, and 50% will have a third episode if there were two previous UTIs in the last 6 months. UTIs are more common in women but more severe in men — incidence 12.6% in women over 18 years versus 0.9–2.4 cases per 1,000 in men over 55 years.
Who gets it, and what grows
Escherichia coli is the most common organism in uncomplicated UTI. The rest of the list is a function of what has been done to the urinary tract — catheters, instrumentation, obstruction, and prior antibiotics.
The organisms, by context
| Setting | Organisms | Detail worth carrying |
|---|---|---|
| E. coli | Most common overall | The single most common causative organism of uncomplicated UTI. |
| Staphylococcus saprophyticus | Uncomplicated UTI | Does not produce nitrate reductase — so the nitrite dipstick may be falsely negative. A classic exam trap. |
| Klebsiella spp. / K. pneumoniae | Uncomplicated, short-term CAUTI | Also appears as ESBL Klebsiella in complicated UTI. |
| Proteus mirabilis | Uncomplicated, long-term CAUTI, recurrent | Most common in elderly men. Urease-splitting — raises urine pH and predisposes to struvite stones. |
| Enterococcus spp. | Uncomplicated, complicated, recurrent | Also lacks nitrate reductase. Needs ampicillin or vancomycin — not a cephalosporin. |
| Resistant gram-negatives | Complicated UTI | ESBL E. coli, Pseudomonas aeruginosa, Acinetobacter baumannii, Staphylococcus spp., and ESBL Klebsiella. |
| Short-term CAUTI group | Catheter < ~30 days | E. coli, Klebsiella spp., Serratia spp., Citrobacter spp., Enterobacter spp. — similar to community organisms. |
| Long-term CAUTI group | Catheter > ~30 days | Typically polymicrobial: P. mirabilis, Morganella morganii, Providencia stuartii, Candida spp., plus the short-term species. |
Candiduria is common with indwelling catheters and does not by itself require treatment. It is treated when the patient is symptomatic — fluconazole 200–400 mg/day for 14 days — and, as always, the ideal first move is removing or exchanging the catheter.
Risk factors — undivided and by gender
Both genders
- Diabetes mellitus
- Urinary instrumentation and catheterization
- Obstruction of normal urine flow — calculi, tumors, urethral strictures
- Neurogenic bladder — stroke, multiple sclerosis, spinal cord injury
- Vesicoureteral reflux
Women
- Short urethra
- Sexual intercourse; a new sexual partner within the past year
- Spermicide or diaphragm, with or without spermicide
- Pregnancy
- History of UTI — personal childhood history in premenopausal women under 15 years; a first-degree female relative
- Urinary incontinence
Men
- Prostatic enlargement, resulting in residual urine
- Prostatitis
- Lack of circumcision
- Sexual partner with vaginal colonization by uropathogens
- HIV infection
Healthcare-associated
- Indwelling urinary catheter — the dominant modifiable risk
- Biofilm formation along the catheter lumen
- Prior antibiotic exposure — selects resistant organisms
- Advanced age and functional impairment
- Long-term care residence
Symptoms tell you where; the urinalysis confirms
The history and examination decide whether to test and where the infection is. The urinalysis and culture confirm it. Imaging is reserved for specific questions.
Symptoms by level of the tract
| Lower tract — cystitis / urethritis / prostatitis | Upper tract — pyelonephritis / renal abscess | |
|---|---|---|
| Symptoms | Dysuria · urinary frequency · urgency · suprapubic pain · hematuria with bacteriuria · malodorous urine · incontinence. Fever and chills are uncommon but may be present. | Flank pain or costovertebral-angle tenderness · fever > 38 °C · hematuria · nausea and vomiting · malaise · shaking chills (rigors) · tachypnea and tachycardia related to fever. |
| The discriminator | No flank or costovertebral pain. No fever in the classic presentation. | Fever plus flank pain. If symptoms last longer than 3 days, consider abscess formation. |
- Recurrent UTIs may require a pelvic examination — the probability of UTI is reduced when vaginal discharge or irritation is present, which points toward vaginitis or an STI instead.
- In an older adult, new confusion or a fall may be the only sign. Absence of dysuria does not exclude infection, and presence of confusion alone does not diagnose it.
Laboratory and imaging
| Test | Finding | Interpretation and traps |
|---|---|---|
| Urine culture and sensitivity | Detection of bacteria in culture | The diagnostic gold standard. Results are not available until 24 hours after collection; point-of-care testing aids early detection. Always obtain before antibiotics if it will not delay treatment. |
| Clean-catch midstream urinalysis | Positive nitrite or leukocyte esterase | Either can diagnose UTI; blood in the urine may also support the diagnosis. |
| Urine microscopy | Pyuria: > 10 leukocytes/mL. Bacteriuria: > 100,000 bacteria/mL | Bacteriuria at this threshold indicates active infection. In acute pyelonephritis expect occasional erythrocytes, white cell casts, mild proteinuria, and an elevated ESR. |
| Leukocyte esterase dipstick | Positive — purple in 60 seconds | Signifies pyuria/WBCs. False positives: kidney stones, tumors, urethritis, poor collection technique. False negatives: uncomplicated or early UTIs. |
| Nitrate dipstick | Positive — pink in 30 seconds | False negatives: uncomplicated UTI, diuretics early in the course, inadequate dietary nitrates, and bacteria that do not produce nitrate reductase — S. saprophyticus, Enterococcus, Pseudomonas. |
| CBC | Leukocytosis with a left shift | Expected in acute pyelonephritis. A WBC above 15,000 suggests infection rather than sterile inflammation. |
| Blood culture | Bacteremia | Indicated for suspected pyelonephritis or sepsis. |
| Imaging | Post-void residual · voiding cystourethrography · CT abdomen/pelvis with and without contrast · pelvic ultrasound · pelvic MRI | To rule out urinary retention, obstruction, calculi, and papillary necrosis in men with UTIs and in women with recurrent UTIs. |
Persistent fever or positive blood cultures after the first 3–4 days suggests you must investigate for obstruction and/or abscess. Abdominal imaging (CT, ultrasound, MRI) and a urologic consult may be necessary. An obstructed infected kidney is a surgical problem — antibiotics alone will not fix it.
Hypotension plus altered mental status in a patient with a urinary source is urosepsis. The genitourinary tract is the most common cause of sepsis in the elderly, and sepsis is a distributive shock state: vasodilation, venous pooling, and relative hypovolemia. At that point the patient is no longer a UTI — see the sepsis report and run the Hour-1 bundle.
Match the regimen to the setting
Duration and route follow the classification: uncomplicated lower tract is 3–5 days oral, upper tract is longer and sometimes parenteral, and complicated infection follows the antibiogram. Fluoroquinolones should only be used when no other alternative is available.
Uncomplicated lower UTI (cystitis) — first- and second-line
For uncomplicated cystitis in women, symptom relief and behavioral measures should be trialed before immediate treatment with antimicrobial agents. Not every dysuria needs an antibiotic.
| Agent | Dose | Notes |
|---|---|---|
| Nitrofurantoin monohydrate/macrocrystal (Macrobid) | 100 mg PO BID for 5 days | First-line. Excellent for cystitis; does not treat pyelonephritis because it does not reach adequate renal tissue levels. |
| TMP-SMX (Bactrim DS) | 160/800 mg PO BID for 3 days | First-line when local resistance is low. The 3-day regimen is preferred over single-dose because of high relapse rates with single dosing. Can extend to 7 days; can be ineffective with resistant organisms. |
| Trimethoprim | 100 mg PO BID for 3 days | Inform by local antimicrobial resistance patterns. |
| Fosfomycin | 3 g PO single dose | Expensive; evidence remains unclear because of increasing resistance. |
| β-lactams — second-line | amoxicillin-clavulanate 500/125 mg PO q12h or 875/125 mg q12h (severe); cefdinir 300 mg q12h; cefaclor 250–500 mg q8h; cefpodoxime 100 mg q12h — for 3–7 days | Used only when other agents cannot be used, due to inferior efficacy and more adverse effects. |
| Fluoroquinolones | Not first-line for cystitis | Reserve for when no other alternative is available. |
Uncomplicated upper UTI (pyelonephritis) — outpatient
| Agent | Dose | Notes |
|---|---|---|
| Ciprofloxacin | 500 mg BID PO for 7 days OR extended-release 1 g daily PO for 7 days | May give an initial IV 400 mg dose before the oral dose. |
| Levofloxacin | 750 mg daily PO for 5 days | If fluoroquinolone resistance exceeds 10%, give an initial 1 g ceftriaxone IV or a consolidated 24-hour aminoglycoside dose. |
| TMP-SMX | 160/800 mg BID PO for 14 days | If susceptibility is unknown, consider an initial IV 1 g ceftriaxone or a consolidated 24-hour aminoglycoside. Empiric use is not recommended because of resistance. Use cautiously in impaired renal function; encourage oral fluids. |
| Oral β-lactams | amox-clav 500/125 mg q12h or 875/125 mg q12h; cefdinir 300 mg q12h; cefaclor 250–500 mg q8h; cefpodoxime 100 mg q12h — for 10–14 days | May not be as effective as the fluoroquinolones or TMP-SMX. |
Complicated lower & upper UTI — inpatient
Complicated UTI is treated based on hospital and community antibiograms, not on habit. Treat the same as uncomplicated if the patient is not severely ill; broaden and lengthen when they are. May complete with oral therapy when afebrile for 48 hours.
- Levofloxacin 750 mg IV q24h for 5 days or 250 mg IV q24h for 10 days
- Ciprofloxacin 200–400 mg IV q12h for ' '7–14 days — black box: tendinitis, tendon rupture, peripheral neuropathy, exacerbation of myasthenia gravis, CNS effects
- Add an aminoglycoside (gentamicin or tobramycin 2 mg/kg IV q8h pending culture; consider renal doses; monitor peak and trough)
- Ceftriaxone 1–2 g/day IV or IM q12–24h ' 'for 10–14 days
- Cefepime 0.5–1 g IV/IM q12h for ' '7–10 days (mild-to-moderate) and 2 g IV q12h for ' '10 days (severe)
- Piperacillin/tazobactam 3.375 g IV q6h for ' '7–10 days
- Aminoglycoside + ampicillin — gentamicin 1 mg/kg IV q8h with ampicillin 1 g IV q6h ' 'for 14 days
May complete with PO when afebrile 48 hr (levofloxacin 750 mg PO daily or ciprofloxacin 500 mg PO ' 'BID). High C. difficile risk with fluoroquinolones.
Treat for 14 days based on susceptibility.
- Ceftriaxone 1 g IV q24h; ceftazidime 1–2 g IV q8h
- Piperacillin/tazobactam 3.375–4.5 g IV ' 'q6h
- Aminoglycosides — gentamicin or tobramycin: consult a pharmacist for pharmacokinetics. May be added initially but never used as monotherapy for ' 'pyelonephritis.
- Sulfonamides — TMP-SMX (trimethoprim component) 8–10 mg/kg/day IV in 2–4 divided doses q6/8/12h for up to ' '14 days
- Penicillin-allergic — aztreonam 1–2 g ' 'q8h IV, ciprofloxacin 200–400 mg q12h IV, or ' 'levofloxacin 500 mg QD IV
Surgery may be necessary when a structural abnormality or a large stone is blocking the urinary tract.
- Consider removing or replacing catheters that have been in place longer than 7 days prior to initiation of treatment.
- Bacterial CAUTI: treat with an antibiotic for 3–7 days. Delayed clinical response, bacteremia, hypotension, or severe sepsis may require 10–14 days.
- Candiduria with symptoms: fluconazole ' '200–400 mg/day for 14 days.
- Nitrofurantoin 100 mg PO BID for ' '5–7 days — except in the first trimester or near term, when you use amoxicillin 500 mg PO TID for 3–7 days or amoxicillin/clavulanate 500 mg PO TID for 3–7 days.
- Fosfomycin 3 g PO single dose.
- Cephalexin 500 mg PO QID for 3–7 days.
- Fluoroquinolones cannot be given during pregnancy.
- Sulfonamides cannot be given near the time of delivery.
- TMP-SMX, nitrofurantoin, and most β-lactams are safe during lactation and breastfeeding.
Symptom relief
- Phenazopyridine 200 mg PO TID for 2 days — may cause red-orange discoloration of body fluids including urine.
- Ibuprofen 400 mg PO TID for 3 days.
Prevention & behavioral measures
- Abstinence or reduction in sexual activity; consider contraception other than spermicides (they alter vaginal flora).
- Oral cranberry products for asymptomatic bacteriuria, especially in pregnant women — less effective than low-dose antimicrobial prophylaxis.
- Postmenopausal women: topical estrogen to normalize vaginal flora; probiotics: oral lactobacillus.
- Increase water intake, decrease carbonated drinks, do not delay urination, early post-coital voiding, wipe front to back.
- Aseptic technique for indwelling catheters; silver-impregnated catheters reduce catheter-related infections.
Prophylaxis for recurrent lower UTI
Postcoital single dose after intercourse: nitrofurantoin 50–100 mg ' 'PO; TMP-SMX 40/200 mg or 80/400 mg ' 'PO; TMP 100 mg PO; ciprofloxacin 250 mg ' 'PO.
Continuous at bedtime: nitrofurantoin 50–100 mg; TMP-SMX 40/200 mg; TMP 100 mg; cephalexin 125–250 mg.
6 months of treatment, followed by observation for reinfection after discontinuing, has been recommended. May reduce risk in female patients with two episodes within 6 months or at least three within a year.
No need to repeat urinalysis with culture and sensitivity after therapy in uncomplicated cystitis and pyelonephritis — but it must be repeated in pregnant women.
The five entities the syllabus flags
| Entity | What separates it |
|---|---|
| Pyelonephritis | Infection of the upper urinary tract (kidney). Flank pain, fever, hematuria, nausea, rigors. Labs: leukocytosis with left shift, elevated ESR, white cell casts, mild proteinuria. > 3 days of symptoms suggests abscess. |
| Urosepsis | The systemic response to a urinary source — hypotension, altered mental status, organ dysfunction. A sepsis resuscitation, not just an antibiotic choice. |
| Urethritis | Inflammation limited to the urethra. Dysuria with discharge — consider STI and treat accordingly; a pelvic examination may be needed. |
| Glomerulonephritis | Immune-mediated glomerular injury — hematuria, proteinuria, red cell casts, hypertension. Not an infection of the collecting system and not treated with antibiotics. |
| Nephrotic syndrome | Massive proteinuria (> 3.5 g/day), hypoalbuminemia, edema. A podocyte/glomerular problem, not a urinary infection. |
Geriatric considerations
Older adults may present with confusion, falls, or functional decline without dysuria or fever. The same features make it easy to over-diagnose — a positive urine culture in a confused elder may be asymptomatic bacteriuria plus delirium from another cause.
Proteus mirabilis is most common in elderly men. Long-term catheterization brings polymicrobial and Candida infection. The GU tract is the most common source of sepsis in the elderly.
The decisions, in order
Two flows. The first answers "does this patient have a UTI and what do I do with it." The second answers "is this UTI now a sepsis resuscitation."
Algorithm 1 — Suspected UTI: classify, then treat
Upper + uncomplicated (outpatient) → oral ciprofloxacin 7 days or levofloxacin 5 days.
Complicated → per hospital and community antibiogram, broader coverage, longer duration; add an aminoglycoside pending culture if ill.
Culture first when it is feasible without delaying antibiotics. Every hour of delay in septic shock costs survival — but in a stable outpatient, the culture changes what you prescribe.
Algorithm 2 — From urosepsis to the sepsis bundle
Afebrile or low-grade fever, hemodynamically normal, tolerating oral intake, normal ' mentation.
- Oral therapy by site and classification
- Outpatient management with follow-up
- No blood cultures required
Fever with rigors, tachycardia, tachypnea, but MAP ≥ 65 and no altered ' 'mentation.
- Admit; obtain blood cultures and urine culture
- IV antibiotics directed at the antibiogram
- Measure lactate
- Treat 7–14 days per severity and response
Hypotension plus altered mental status, or MAP < 65 despite fluids, ' 'or lactate ≥ 4.
- Run the Hour-1 bundle — lactate, cultures, broad-spectrum ' 'antibiotics, 30 mL/kg crystalloid for hypotension or lactate ' '≥ 4, vasopressors to MAP ≥ 65
- Search for obstruction — an infected obstructed system needs ' 'urgent drainage
- Urology and critical care involvement
In most sepsis, source control means drainage or debridement. In urosepsis it means relieving obstruction — a nephrostomy tube or ureteral stent for an obstructed infected kidney, or exchanging a chronically indwelling catheter that has become a biofilm reservoir. Antibiotics cannot sterilize an obstructed, pressurized collecting system. If the patient is not improving on appropriate antibiotics, the question is not "which drug" — it is "what is still blocked?"
Where UTI sits beside the other three
These comparisons exist because the same clinical situation shows up in two topics at once. Knowing which is which is the exam skill.
Antibiotic coverage — the four topics side by side
| Topic | Is an antibiotic the answer? | What is chosen, and why |
|---|---|---|
| UTI | Usually yes — but not for asymptomatic bacteriuria. | Narrow and short for uncomplicated cystitis (nitrofurantoin, TMP-SMX, fosfomycin, 3–5 days). Broader and longer for pyelonephritis and complicated infection, guided by the antibiogram. Avoid fluoroquinolones unless nothing else works. |
| Pneumonia | Yes when bacterial pneumonia is the working diagnosis. | CAP outpatient: macrolide or doxycycline. CAP ward: ceftriaxone plus azithromycin or doxycycline. CAP ICU: β-lactam plus macrolide or respiratory fluoroquinolone. HAP/VAP: antipseudomonal β-lactam ± second agent, plus MRSA coverage if at risk. |
| Sepsis | Yes, and fast — within 1 hour in shock. | Broad-spectrum, at least two agents of different classes, aimed at the most likely pathogens and informed by local resistance patterns. 7–10 days for most serious infections; de-escalate daily on culture data. |
| CHF | No — unless there is a concurrent infection. | Infection is a precipitant of decompensation, not the disease. Treat the infection and the heart failure simultaneously; antibiotics do not treat congestion. |
The same drug, a different job
| Agent | In UTI | In pneumonia | In sepsis | In CHF |
|---|---|---|---|---|
| Nitrofurantoin | First-line cystitis, 5 days | — | — | Avoid in significant renal impairment; listed as a drug cause of pulmonary reactions in interstitial lung disease |
| Fluoroquinolones | Reserve — only when no alternative | Respiratory FQ is a CAP backbone option | A possible component of broad coverage | — (black box warnings; tendon and CNS effects) |
| Vancomycin | Complicated UTI with gram-positive concern | MRSA coverage in HAP/VAP and severe CAP | Commonly part of empiric gram-positive coverage | — |
| Loop diuretics | — | — | Used with caution — volume assessment is the point | Class of choice for congestion; IV loop first in ADHF |
| Vasopressors | Only if urosepsis with shock | Only if septic shock | Norepinephrine first-line, target MAP ≥ 65 | Generally harmful in cardiogenic shock — inotropes are the answer |
- Older adult with confusion and a positive urine culture — is this UTI, or asymptomatic bacteriuria plus delirium from something else? Look for fever, flank pain, and leukocytosis before treating the number.
- Dyspneic patient with rales, hypoxia, and a fever — pneumonia and decompensated heart failure can present identically and can coexist. BNP helps separate cardiac from pulmonary etiology; remember that infection precipitates heart failure decompensation.
- Patient with CHF who develops a UTI — be careful with fluid boluses and with nephrotoxic agents; both the infection and the congested heart can push toward acute kidney injury.
- Urosepsis in a patient with CHF — the hardest one. Fluid resuscitation is indicated, but the failing heart tolerates it poorly. Resuscitate with reassessment at small intervals, use bedside ultrasound or IVC assessment, and escalate vasopressors earlier rather than pouring in volume.
The 12 facts to carry into clinicals
- E. coli is the most common organism in uncomplicated UTI; S. saprophyticus is a classic uncomplicated pathogen that does not produce nitrate reductase, so the nitrite dipstick can be falsely negative.
- Uncomplicated = normal working urinary tract. Complicated = a defect in the tract or a compromising host condition. This distinction drives drug and duration.
- Colony thresholds are symptom- and specimen-dependent. Between 10 and 10,000 colonies can be real infection when symptoms are present; asymptomatic bacteriuria needs > 100,000 in two consecutive female samples or one male sample.
- Screen for asymptomatic bacteriuria only in pregnancy, before invasive GU procedures, and in renal transplant recipients.
- Lower tract has no flank pain. Fever plus costovertebral-angle tenderness means upper tract; symptoms beyond 3 days raise concern for abscess.
- First-line cystitis: nitrofurantoin 100 mg BID × 5 days; TMP-SMX 160/800 BID × 3 days; fosfomycin 3 g single dose. β-lactams are second-line.
- Nitrofurantoin does not treat pyelonephritis — it concentrates in urine, not renal tissue.
- Pyelonephritis outpatient: ciprofloxacin 500 mg BID × 7 days or levofloxacin 750 mg daily × 5 days. Severely ill inpatient: 14 days by susceptibility.
- Aminoglycosides are never monotherapy for pyelonephritis — they may be added initially pending culture.
- CAUTI: consider removing or replacing a catheter in place longer than 7 days before treating; treat 3–7 days, or 10–14 with delayed response, bacteremia, hypotension, or severe sepsis.
- Pregnancy changes everything: no fluoroquinolones; no sulfonamides near delivery; nitrofurantoin avoided in the first trimester and near term; always repeat the culture after treatment.
- Persistent fever or positive blood cultures at day 3–4 means look for obstruction or abscess — image and consult urology.
- Treating a number instead of a patient. A positive culture in someone without urinary symptoms is usually asymptomatic bacteriuria — and antibiotics cause harm.
- Using nitrofurantoin for pyelonephritis. It is a urinary tract antiseptic, not a tissue antibiotic.
- Escalating antibiotics in an obstructed system. No drug reaches an obstructed, pressurized kidney. Drain it.
Six questions, then reveal
Answer out loud before you open each one. The rationale explains why the other options fail.
A 74-year-old woman has an indwelling urinary catheter placed on hospital day 1. On day 3 she has a temperature of 38.6 °C with suprapubic pain and cloudy, malodorous urine. What makes this a CAUTI?
A UTI is catheter-associated when the patient has been catheterized within the past 48 hours. The catheter provides a surface for biofilm — a layer of uropathogens living along the catheter — which is why CAUTI organisms and their susceptibilities differ from community-acquired infection.
More than 100,000 colonies in two consecutive female samples without urinary symptoms describes asymptomatic bacteriuria, not CAUTI. Fever with flank pain and costovertebral-angle tenderness describes pyelonephritis. And the practical point: 69% of CAUTIs are avoidable by avoiding catheters and removing them as soon as they are no longer medically necessary.
Which patient should be screened for asymptomatic bacteriuria?
Pregnant women — along with patients undergoing invasive genitourinary procedures and renal transplant recipients. Routine screening is not indicated otherwise.
Diabetes is a risk factor for UTI but is not an indication for screening asymptomatic bacteriuria. Age alone does not justify screening, even though UTI is the most common bacterial infection in the elderly. A personal or first-degree family history of UTI is a contributing factor in women, not a screening indication.
A woman with uncomplicated cystitis has no allergies and lives in an area with low TMP-SMX resistance. Which is a first-line regimen?
Nitrofurantoin monohydrate/macrocrystal 100 mg PO BID for 5 days is first-line, as is TMP-SMX 160/800 mg PO BID for 3 days and fosfomycin 3 g PO as a single dose.
The 3-day TMP-SMX regimen is preferred over single-dose because of high relapse rates with single dosing — but 14 days is a pyelonephritis duration, not a cystitis one. β-lactams such as amoxicillin-clavulanate are second-line, appropriate only when other recommended agents cannot be used, because of inferior efficacy and more adverse effects.
Which agent should NOT be used as monotherapy for pyelonephritis?
Aminoglycosides. Gentamicin or tobramycin may be added initially while cultures are pending, but they are not used as monotherapy for pyelonephritis — consult a pharmacist for pharmacokinetic dosing.
Cephalosporins such as ceftriaxone and cefepime, penicillins such as piperacillin/tazobactam, and antipseudomonal β-lactams all have a role in complicated or severe upper tract infection. In pregnancy, penicillins are actually preferred.
A 66-year-old woman is admitted with pyelonephritis. She is febrile with rigors and tachycardic, but her MAP is 78 mmHg and she is alert and oriented. What is the immediate priority?
Obtain blood and urine cultures, measure lactate, and start IV antibiotics directed by the local antibiogram — she is systemically unwell but perfusing, so this is not yet septic shock.
If she were hypotensive with altered mental status, the priority changes to the Hour-1 bundle: lactate, cultures, broad-spectrum antibiotics, 30 mL/kg crystalloid for hypotension or lactate ≥ 4 mmol/L, and vasopressors to keep MAP ≥ 65 mmHg. Either way, remember that the GU tract is the most common source of sepsis in the elderly.
A man with pyelonephritis has been on appropriate IV antibiotics for 4 days but remains febrile. What is the next step?
Investigate for obstruction and/or abscess. Persistent fever or positive blood cultures after the first 3–4 days should prompt abdominal imaging (CT, ultrasound, or MRI) and a urologic consult. Surgery may be necessary when a structural abnormality or a large stone is blocking the urinary tract.
Simply broadening or extending antibiotics misses the diagnosis. An infected obstructed collecting system is under pressure — no antibiotic reaches it adequately, and the kidney is being destroyed while you wait. Source control here means drainage: nephrostomy tube, ureteral stent, or stone removal.
Sources
Every clinical statement on this page traces to one of the sources below. Course readings are cited by chapter so you can find the original; guidelines are cited by year and issuing body so you can check whether a newer version has appeared.
Talley, C., & Langley, K. (2021). Urinary tract infections (Chapter 42). In Practice considerations for adult-gerontology acute care nurse practitioners (3rd ed.). The primary assigned reading. Source of the UTI definition, colony-count thresholds, asymptomatic bacteriuria screening criteria, CAUTI 48-hour definition and biofilm mechanism, the 69% avoidable figure, organism lists by setting, risk factors by gender, symptoms by tract level, all laboratory and imaging recommendations, and every antibiotic regimen and dose reproduced on this page.
Branham, & Hilliard (2021). Acute kidney injury and chronic kidney disease (Chapter 43). Context for renal function, creatinine and GFR interpretation, and drug dosing in renal impairment — relevant to the renal cautions attached to nitrofurantoin, TMP-SMX, and the aminoglycosides.
Couture (2021). Nephrolithiasis (Chapter 46). Source of the struvite calculus association with recurrent UTI and urease-splitting organisms such as Proteus mirabilis, and of the urosepsis flag — hypotension plus altered mental status in a patient with stones.
Blessing, R., & Sabol, V. K. (2021). Management of the patient in shock (Chapter 76). Source of the sepsis definitions used in Algorithm 2, the Hour-1 bundle elements, vasopressor doses and targets, and the statement that the genitourinary tract is the most common cause of sepsis in the elderly.
N5301 Week 6 course materials — Genitourinary Disorders I lecture slides and the week 6 practice question set. Source of the specific CAUTI criterion tested in the course format, the asymptomatic bacteriuria screening indications, the first-line cystitis regimens, and the statement that aminoglycosides are not used as monotherapy for pyelonephritis.
N5301 Week 7 course materials — Genitourinary Disorders II lecture slides. Source of the struvite/recurrent-UTI linkage and the urine pH greater than 7–7.5 association.
Infectious Diseases Society of America / European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women (2010, and subsequent updates). The guideline behind the first-line nitrofurtantoin, TMP-SMX, and fosfomycin recommendations, and behind the caution to reserve fluoroquinolones. Verify the current version before relying on it clinically.
Infectious Diseases Society of America. Clinical practice guideline for the management of asymptomatic bacteriuria (2019). The basis for not screening or treating asymptomatic bacteriuria outside pregnancy, invasive urologic procedures, and renal transplant. Verify the current version.
Open the sources yourself
Direct links, so you can read the guideline rather than take my word for it. Open access means the full text is free; opens in browser means the publisher blocks automated checks but the page loads normally for you.
Guidelines and primary sources for this topic
Shared reference pages
This is a study aid built from course readings and published guidelines, not a standing order set. Doses are the ones those sources print — but your patient's renal function, weight, allergies, pregnancy status, and your institution's antibiogram and formulary decide what is actually given. Confirm every drug against your facility's policy and a current reference, and escalate to your preceptor rather than extrapolating from a study page.